| Clinical data | |
|---|---|
| Other names | ORG-OM-38; Delta-4-Tibolone; 7α-Methylnorethisterone; 7α-Methyl-17α-ethynyl-19-nortestosterone; 17α-Ethynyl-17β-hydroxy-7α-methyl-4-estren-3-one |
| Identifiers | |
| |
| CAS Number | |
| PubChemCID | |
| ChemSpider | |
| UNII | |
| Chemical and physical data | |
| Formula | C21H28O2 |
| Molar mass | 312.453 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
δ4-Tibolone (developmental code nameORG-OM-38), also known as7α-methylnorethisterone or as7α-methyl-17α-ethynyl-19-nortestosterone, is asyntheticandrogen andprogestin which was never marketed.[1][2] The compound is a majoractive metabolite oftibolone, which itself is aprodrug of δ4-tibolone along with3α-hydroxytibolone and3β-hydroxytibolone (which, in contrast to δ4-tibolone, areestrogens).[1] Tibolone and δ4-tibolone are thought to be responsible for the androgenic and progestogenic activity of tibolone, while 3α-hydroxytibolone and 3β-hydroxytibolone are thought to be responsible for itsestrogenic activity.[1]
Thisdrug article relating to thegenito-urinary system is astub. You can help Wikipedia byexpanding it. |